(19)
(11) EP 1 733 058 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
24.10.2012 Bulletin 2012/43

(45) Mention of the grant of the patent:
05.09.2012 Bulletin 2012/36

(21) Application number: 04756860.5

(22) Date of filing: 12.07.2004
(51) International Patent Classification (IPC): 
C13K 3/00(2006.01)
A61K 31/7016(2006.01)
 C07H 3/04(2006.01)
A61P 7/06(2006.01)
(86) International application number:
PCT/US2004/022179
(87) International publication number:
WO 2005/094202 (13.10.2005 Gazette 2005/41)

(54)

IRON SUCROSE COMPLEXES AND METHOD OF MANUFACTURE THEREOF

EISEN-SACCAROSE-KOMPLEXE UND VERFAHREN ZU DEREN HERSTELLUNG

COMPLEXES DE SUCROSE DE FER ET PROCEDE DE FABRICATION DE CEUX-CI

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 16.03.2004 US 553712 P

(43) Date of publication of application:
20.12.2006 Bulletin 2006/51

(73) Proprietor: Navinta LLC
Ewing, NJ 08618-1414 (US)

(72) Inventors:
  • NEWTON, Cristopher, Benny
    Plainsboro, NJ 08536 (US)
  • RANGISETTY, Jagadeesh, Babu
    Lawrenceville, NJ 08648 (US)

(74) Representative: Ouzman, Beverley Nicola Claire 
Murgitroyd & Company Scotland House 165-169 Scotland Street
Glasgow G5 8PL
Glasgow G5 8PL (GB)


(56) References cited: : 
DE-C- 862 482
US-A- 4 994 283
US-B2- 6 537 820
 IN-A1- 187 116
US-A1- 2003 216 566
   
  • FAICH G ET AL: "SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE: SAFER INTRAVENOUS IRON THERAPY THAN IRON DEXTRANS" AMERICAN JOURNAL OF KIDNEY DISEASES, W.B. SAUNDERS, PHILADELPPHIA, PA, US, vol. 33, no. 3, 1 March 1999 (1999-03-01), pages 464-470, XP009014641 ISSN: 0272-6386
  • DATABASE CAPLUS [Online] 'An improved process for preparing saccharated iron oxide in powder form for use in tablets as well as for syrup preparation', XP008107189 Retrieved from STN Database accession no. (2004:1026272) & IN 187 116 A1
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).